Abbott has partnered with Google Health to integrate data from its over-the-counter Lingo continuous glucose monitor into the Google Health app, allowing users to view metabolic data and receive AI-driven recommendations from Google Health Coach. The multi-year deal is aimed at helping people make better nutrition and lifestyle choices, though Lingo is designed for non-diabetic adults who don't use insulin, a group for which the health benefits of glucose monitoring remain scientifically unclear.

Previous reporting, including from Johns Hopkins Bloomberg School of Public Health, has found little evidence that continuous glucose monitoring benefits non-diabetics, since their bodies can typically regulate blood sugar spikes naturally, and over-focusing on glucose readings could encourage unnecessarily restrictive eating habits. Experts, including a doctor known online as Dr Idz, have also warned that laypeople often cannot meaningfully interpret CGM data without additional context. As part of the partnership, Abbott and Google plan to run one of the largest real-world metabolic health studies to date, combining glucose, wearable, laboratory and survey data, though critics note the collaboration could also boost sales of Lingo devices and Google Health Premium subscriptions.